Skip to main content

Table 2 Follow-up outcomes by presence of DM with corresponding HR

From: Prognostic significance of diabetes mellitus in patients with atrial fibrillation

Outcome DM Non-DM Adjusted HR* (95% CI)
All-cause death 171/373 (45.8%) 243/736 (33%) 1.40 (1.11–1.75)
CV-death 130/373 (34.9%) 173/736 (23.5%) 1.39 (1.07–1.81)
Sudden cardiac death 72/373 (19.3%) 80/736 (10.9%) 1.73 (1.19–2.52)
HF-realetd death 50/373 (13.4%) 71/736 (9.6%) 1.28 (0.86–1.91)
Major bleeding** 18/340 (5.3%) 29/644 (4.5%) 1.50 (0.78–2.87)
Stroke** 24/340 (7.1%) 28/645 (4.3%) 1.87(1.01–3.45)
AF-related hospitalization** 59/340 (17.4%) 115/645 (17.8%) 1.17 (0.82–1.66)
HF-related hospitalization** 35/333 (10.5%) 46/640 (7.2%) 1.40 (0.89–2.21)
Hospitalization or CV-death 243/373 (65.1%) 399/736 (54.2%) 1.27 (1.06–1.53)
  1. Significant adjusted hazard ratios are marked in italics
  2. *Adjusted for: age, BMI, history of prior stroke, coronary artery disease or prior revascularization procedure, AF subtype, eGFR (CKD-EPI) and use of ACEI-ARB, OAC and rate control medication after discharge
  3. **Competing-risks regression analysis (Fine and Gray 1999) was performed with all-cause death addressed as a competing risk
  4. DM: diabetes mellitus; HR: hazard ratio; AF: atrial fibrillation; CV: cardiovascular; HF: heart failure